NOTE: This order is n0nprecedential. United States Court of Appeals for the FederaI Circuit AVENTIS PHARMACEUTICALS INC., Plaintiff-Appellant, ' AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLECULAR _ RESEARCI~I, INC.), Plaintiff-Appellant, V. __ DR. REDDY’S LABORATORIES, LTD. AND DR. REI)DY’S LABORATORIES, INC., Defendants-Appellees. AVENTIS PHARMACEUTICALS INC., Plaintiff-Appellant, AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLECULAR RESEARCH, INC.), Plaintiff-Appellan,t, V. AMINO CHEMICALS LTD., DIPHARMA FRANCIS, SR.L., AND DIPHARMA SPA, Defen,dants-Appellees,

AVENTIS PHARMA V. DR REDDYS LABS 2 AND MYLAN PHARMACEUTICALS INC., Defendant. AVENTIS PHARMACEUTICALS INC., Plaintiff-Appellant, AND AMR TECHNOLOGY, INC. (NOW KNOWN AS ALBANY MOLEC_ULAR RESEARCH, INC.), Plaintiff-Appella,nt, V. TEVA PHARMACEUTICALS USA, INC., l Defendant~Appellee, AND AMINO CHEMICALS LTD., DIPHARMA FRANCIS, SR.L., AN1) DIPHARMA SPA, Defendcmts-Appellees. 2011-1334, »1335, -1336 Appea1s from the United States District C0urt for the District of New Jersey in case n0s. 04-CV-1075, 04-CV- 107 7, and 04-CV-1078, Chief Judge Garrett E. Br0Wn, Jr. ON MOTION w 0RDER

3 AVENTIS PHARM.A V. DR REDDYS LABS Upon consideration of Aventis Pharmaceutica1s, Inc.’s motion to voluntarily dismiss this appeal as to Mylan Pharmaceuticals, Inc. due to Settlen1ent, IT ls ORDERED THAT: The motion is granted to the extent that the revised official caption is reflected above to indicate that Mylan is no longer an appellee. AUG 2 6 2011 Date ccc AndreW P. Zappia, Esq. Paul H. Berghoff, Esq. Anthony W. Shaw, Esq. Michael E. Patunas, Esq. Martin B. Pavane, Esq. E. Anthony Figg, Esq. s20 FOR THE CoURT fs/ J an Horbaly J an Horbaly Clerk - FlL u.s. count 0FE.zl?PEALs F0R rt-ls FEo£RAL census AUG 2 6 2011 .IAN HBRBALY CLEHi